<?xml version="1.0" encoding="UTF-8"?>
<p>The above activities, which involve the use of products of human origin, from donation to follow-up, are exposed to the risks of specific complications that are mainly related to the transmission of infectious diseases and other adverse effects. For this reason, the bio-vigilance system is a strategic tool for ensuring the quality and safety of tissues and cells, intended for the application of advanced therapies to humans. The bio-vigilance system shall focus on the prevention of errors and along with the strong involvement of clinicians will maintain a consistent standard of agreed assays for treated tissues and cells intended for clinical application, therefore, being an important factor in facilitating innovation [
 <xref rid="R19" ref-type="bibr">19</xref>].
</p>
